Article
New Therapies for Advanced Thyroid Cancer.
Frontiers in endocrinology - 1 Jan 2020
Laha Diprajan, Nilubol Naris, Boufraqech Myriem
Abstract excerpt
Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for thyroid cancer has significantly improved the understanding of the molecular pathogenesis of thyroid cancer, thus allowing more personalized treatments for patients with thyroid cancer. Most of the recently discovered targeted therapies inhibit the known oncogenic mechanisms in thyroid cancer initiation and progression such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
